Document Detail


Procalcitonin as a predictive marker of infections in chemoinduced neutropenia.
MedLine Citation:
PMID:  19876647     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: This study was designed to determine the usefulness of procalcitonin (PCT) as a predictive marker of infections in neutropenic patients following chemotherapeutic treatments. METHODS: Over a 6-month period, 65 patients (34 affected by a solid tumor, 31 by a hematological disorder) were enrolled. Serum PCT concentrations were measured by an automated immunoassay on the leucocytes nadir and on the third day, when patients were checked for any sign of infection. RESULTS: Procalcitonin values were not affected by gender, age, therapeutic approach, use of G-CSF or performance status and did not differ between patients who subsequently developed a localized infection and those who did not. PCT concentrations resulted higher in patients affected by hematological disorders than in those affected by solid tumors (mean value 0.09 vs. 0.05 microg/L; p < 0.0015) and in those who were hospitalized than in the outpatient group (0.10 vs. 0.05 microg/L; p < 0.0013). PCT levels correlated with the type of neoplastic disease (p = 0.016), the highest concentrations being detected in patients affected by acute leukemia. CONCLUSIONS: These findings suggest that PCT is not a useful predictive marker of infection in oncohematologic neutropenic patients, even though higher serum PCT concentrations are associated with hematological tumors as well as in-hospital admission.
Authors:
Luisa Carnino; Silvia Betteto; Maria Loiacono; Annalisa Chiappella; Alice Giacobino; Libero Ciuffreda; Patrizia Lista; Giulio Mengozzi
Related Documents :
16436297 - Analysis of microbial etiology and mortality in patients with brain abscess.
20715727 - Anti-emetic dexamethasone and postoperative infection risk: a retrospective cohort study.
6988557 - Infections in leukemic children: a prospective analysis.
1393867 - Prevention of herpes simplex virus infection by oral acyclovir after cardiac transplant...
15315997 - Vitamin e and respiratory tract infections in elderly nursing home residents: a randomi...
23505697 - Prevalence of salmonella enterica serovar albany in captive zoo wild animals in the cul...
Publication Detail:
Type:  Journal Article     Date:  2009-10-30
Journal Detail:
Title:  Journal of cancer research and clinical oncology     Volume:  136     ISSN:  1432-1335     ISO Abbreviation:  J. Cancer Res. Clin. Oncol.     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-02-19     Completed Date:  2010-05-14     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7902060     Medline TA:  J Cancer Res Clin Oncol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  611-5     Citation Subset:  IM    
Affiliation:
Oncohematological Center, San Giovanni Battista University Hospital, Turin, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biological Markers / blood
Calcitonin / blood*
Female
Hematologic Neoplasms / drug therapy
Humans
Infection / blood,  diagnosis*,  etiology
Male
Neoplasms / drug therapy
Neutropenia / chemically induced*,  complications,  pathology
Protein Precursors / blood*
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Protein Precursors; 56645-65-9/procalcitonin; 9007-12-9/Calcitonin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The reaction-time task-rule congruency effect is not affected by working memory load: further suppor...
Next Document:  A novel mutation in the connexin 29 gene may contribute to nonsyndromic hearing loss.